This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $11,040.84 delivery order is for DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and a completion date of September 24, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded this contract without any set-aside...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEWM2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $33,900.74 firm-fixed-price delivery order is for the supply of 4,564,881,014 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The award is not associated with a set-aside designation and has a completion date of July 3, 2024. AmerisourceBergen, a major pharmaceutical distribution company,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $198,735.12 Firm Fixed Price Delivery Order is for the supply of 4,565,227,359 units of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has an ultimate completion date of August 13, 2024 and was awarded on July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,565,892,614 units of the drug DARZALEX FASPRO 1,800MG-30,000 15ML. The $110,408.40 fixed-price contract was awarded on September 20, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency within the Department of Defense. The contract has an ultimate completion date of October 11, 2024 and is not set aside for any specific business category....
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FJE82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $110,408.40 firm-fixed-price delivery order is for the supply of 4565151397 - DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,940.63, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product. It is a firm fixed-price delivery order contract with an ultimate completion date of January 24, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,043,988 units of the specialty drug DARZALEX FASPRO 1,800 MG - 30,000 15 ML. The contract is a firm-fixed price delivery order with a ceiling value of $5,520.42 and a performance period extending through October 29, 2024. As the prime contractor, Amerisourcebergen will be responsible for supplying this critical medication to support the...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the supply of 4,565,119,522 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The $17,481.48 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has an ultimate completion date of August 1, 2024. This contract is not a set-aside award. Amerisourcebergen...
This federal contract award, valued at $124,028.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22FP0U3) for the supply of DARZALEX FASPRO, a specialty medication, with an ultimate completion date of July 22, 2022. The contract is a firm fixed-price arrangement, and no set-aside designation was used. Amerisourcebergen holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $55,204.20 firm fixed-price contract is for the supply of 4,565,255,805 units of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The delivery order has an ultimate completion date of August 15, 2024. This award is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts...